Article Information
- Received July 17, 2000
- Revision received August 23, 2000
- Accepted August 29, 2000
- First published November 15, 2000.
- Version of record published November 15, 2000.
Author Information
Author contributions
Disclosures
- Received July 17, 2000.
- Revision received August 23, 2000.
- Accepted August 29, 2000.
This research was supported by an International Prize Fellowship from the Wellcome Trust (A.C.), a Young Investigator Award from the National Alliance for Schizophrenia and Depression (G.T.S.), the Schweizerische Nationalfond and the Deutsche Forschungsgemeinschaft (A.S.), and the National Institutes of Health and the McKnight Foundation (S.F.H.). We would like to acknowledge the technical efforts of Conny Maron and Lora O'Leary. We also would like to thank Drs. Robert Gereau, Jane Sullivan, and Charles F. Stevens for critical reading of this manuscript.
A.C. and G.T.S. contributed equally to this work.
Correspondence should be addressed to Dr. Anis Contractor, Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037. E-mail:contractor{at}salk.edu.
Dr. Sailer's present address: Merck and Company, Inc., P.O. Box R80M-213, Rahway, NJ 07065.
